Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Aug;72(2):535–544. doi: 10.1172/JCI111001

Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2.

L H Frame, J A Lopez, B A Khaw, J T Fallon, E Haber, W J Powell Jr
PMCID: PMC1129211  PMID: 6223942

Abstract

There is currently great interest in acute coronary reperfusion as a therapeutic modality for severe myocardial ischemia. While some studies have demonstrated a reduction in the overall extent of necrosis by early reperfusion, other studies have identified potentially deleterious effects produced by reflow. Because membrane disruption may be an important mechanism of irreversible cell injury, we measured changes in cell membrane integrity early during reperfusion using radiolabeled anticardiac myosin (Fab')2 antibody fragments in dogs. Our method involved brief periods of exposure to the (Fab')2 so that the levels of (Fab')2 binding indicated the degree of membrane disruption at discrete times during the progression of cell injury. In the first protocol (Fab')2 fragments labeled with either 125I and 131I were injected into the left circumflex coronary artery at the onset of reflow and at 45 min of reflow after a 1-h circumflex artery occlusion. Coronary sinus flow was diverted for 5 min following each injection to prevent recirculation. The (Fab')2 binding ratio (ischemic/control) increased during the first 45 min of reflow in each of eight experiments (mean increase 170%, P less than 0.01). No significant increase in (Fab')2 binding was observed in five additional experiments in which nonspecific (Fab')2 was injected. This indicates that the increase in binding seen with antimyosin-specific (Fab')2 was due to changes in specific binding rather than to alterations in (Fab')2 delivery produced by changes in blood flow distribution. The increase in membrane damage during reflow was confirmed by a second protocol in which each animal received only a single left atrial injection of (Fab')2 followed by rapid excision of the heart. The (Fab')2 binding ratio was 1.7 +/- 0.3 (SEM) in the group that received (Fab')2 at the onset of reflow and 3.7 +/- 0.6 (SEM) (P less than 0.05) in the group that received (Fab')2 after 45 min of reflow. In a third set of experiments in which hyperosmotic mannitol was infused during reflow the mean increase in (Fab')2 binding using the first protocol was only 80 +/- 40 vs. 170 +/- 30% without mannitol (P less than 0.05). Thus, membrane damage develops early during coronary reperfusion following 1 h of circumflex coronary artery occlusion, and part of this membrane damage can be prevented by altering the conditions of reflow. A method involving brief exposure of the myocardium to antimyosin (Fab')2 is promising for detecting changes in membrane integrity during evolving ischemic injury.

Full text

PDF
535

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baughman K. L., Maroko P. R., Vatner S. F. Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs. Circulation. 1981 Feb;63(2):317–323. doi: 10.1161/01.cir.63.2.317. [DOI] [PubMed] [Google Scholar]
  2. Beller G. A., Khaw B. A., Haber E., Smith T. W. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate. Circulation. 1977 Jan;55(1):74–78. doi: 10.1161/01.cir.55.1.74. [DOI] [PubMed] [Google Scholar]
  3. Bresnahan G. F., Roberts R., Shell W. E., Ross J., Jr, Sobel B. E. Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol. 1974 Jan;33(1):82–86. doi: 10.1016/0002-9149(74)90742-5. [DOI] [PubMed] [Google Scholar]
  4. Cohn L. H., Gorlin R., Herman M. V., Collins J. J., Jr Aorto-coronary bypass for acute coronary occlusion. J Thorac Cardiovasc Surg. 1972 Oct;64(4):503–513. [PubMed] [Google Scholar]
  5. DeWood M. A., Spores J., Notske R. N., Lang H. T., Shields J. P., Simpson C. S., Rudy L. W., Grunwald R. Medical and surgical management of myocardial infarction. Am J Cardiol. 1979 Dec;44(7):1356–1364. doi: 10.1016/0002-9149(79)90453-3. [DOI] [PubMed] [Google Scholar]
  6. DiBona D. R., Powell W. J., Jr Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res. 1980 Nov;47(5):653–665. doi: 10.1161/01.res.47.5.653. [DOI] [PubMed] [Google Scholar]
  7. Ganz W., Ninomiya K., Hashida J., Fishbein M. C., Buchbinder N., Marcus H., Mondkar A., Maddahi J., Shah P. K., Berman D. Intracoronary thrombolysis in acute myocardial infarction: experimental background and clinical experience. Am Heart J. 1981 Dec;102(6 Pt 2):1145–1149. doi: 10.1016/0002-8703(81)90645-1. [DOI] [PubMed] [Google Scholar]
  8. Ginks W. R., Sybers H. D., Maroko P. R., Covell J. W., Sobel B. E., Ross J., Jr Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest. 1972 Oct;51(10):2717–2723. doi: 10.1172/JCI107091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jennings R. B. Cell volume regulation in acute myocardial ischemic injury. Acta Med Scand Suppl. 1976;587:83–93. doi: 10.1111/j.0954-6820.1976.tb05870.x. [DOI] [PubMed] [Google Scholar]
  10. Jennings R. B., Ganote C. E., Kloner R. A., Whalen D. A., Jr, Hamilton D. G. Explosive swelling of myocardial cells irreversibly injured by transient ischemia. Recent Adv Stud Cardiac Struct Metab. 1975;6:405–413. [PubMed] [Google Scholar]
  11. Khaw B. A., Beller G. A., Haber E. Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin. Circulation. 1978 Apr;57(4):743–750. doi: 10.1161/01.cir.57.4.743. [DOI] [PubMed] [Google Scholar]
  12. Khaw B. A., Beller G. A., Haber E., Smith T. W. Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest. 1976 Aug;58(2):439–446. doi: 10.1172/JCI108488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Khaw B. A., Fallon F. T., Strauss H. W., Haber E. Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science. 1980 Jul 11;209(4453):295–297. doi: 10.1126/science.7384803. [DOI] [PubMed] [Google Scholar]
  14. Khaw B. A., Fallon J. T., Beller G. A., Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation. 1979 Dec;60(7):1527–1531. doi: 10.1161/01.cir.60.7.1527. [DOI] [PubMed] [Google Scholar]
  15. Khaw B. A., Gold H. K., Leinbach R. C., Fallon J. T., Strauss W., Pohost G. M., Haber E. Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments. Circulation. 1978 Dec;58(6):1137–1142. doi: 10.1161/01.cir.58.6.1137. [DOI] [PubMed] [Google Scholar]
  16. Khaw B. A., Scott J., Fallon J. T., Cahill S. L., Haber E., Homcy C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science. 1982 Sep 10;217(4564):1050–1053. doi: 10.1126/science.7051286. [DOI] [PubMed] [Google Scholar]
  17. Kloner R. A., Ganote C. E., Jennings R. B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974 Dec;54(6):1496–1508. doi: 10.1172/JCI107898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kloner R. A., Ganote C. E., Whalen D. A., Jr, Jennings R. B. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol. 1974 Mar;74(3):399–422. [PMC free article] [PubMed] [Google Scholar]
  19. Leaf A. Cell swelling. A factor in ischemic tissue injury. Circulation. 1973 Sep;48(3):455–458. doi: 10.1161/01.cir.48.3.455. [DOI] [PubMed] [Google Scholar]
  20. Lie J. T., Pairolero P. C., Holley K. E., Titus J. L. Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg. 1975 Apr;69(4):599–605. [PubMed] [Google Scholar]
  21. Marchalonis J. J. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969 Jun;113(2):299–305. doi: 10.1042/bj1130299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Maroko P. R., Libby P., Ginks W. R., Bloor C. M., Shell W. E., Sobel B. E., Ross J., Jr Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest. 1972 Oct;51(10):2710–2716. doi: 10.1172/JCI107090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mathey D. G., Kuck K. H., Tilsner V., Krebber H. J., Bleifeld W. Non surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation. 1981 Mar;63(3):489–497. doi: 10.1161/01.cir.63.3.489. [DOI] [PubMed] [Google Scholar]
  24. Phillips S. J., Kongtahworn C., Zeff R. H., Benson M., Iannone L., Brown T., Gordon D. F. Emergency coronary artery revascularization: a possible therapy for acute myocardial infarction. Circulation. 1979 Aug;60(2):241–246. doi: 10.1161/01.cir.60.2.241. [DOI] [PubMed] [Google Scholar]
  25. Powell W. J., Jr, DiBona D. R., Flores J., Leaf A. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation. 1976 Oct;54(4):603–615. doi: 10.1161/01.cir.54.4.603. [DOI] [PubMed] [Google Scholar]
  26. Reduto L. A., Smalling R. W., Freund G. C., Gould K. L. Intracoronary infusion of streptokinase in patients with acute myocardial infarction: effects of reperfusion on left ventricular performance. Am J Cardiol. 1981 Sep;48(3):403–409. doi: 10.1016/0002-9149(81)90066-7. [DOI] [PubMed] [Google Scholar]
  27. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  28. Rentrop P., Blanke H., Karsch K. R., Kaiser H., Köstering H., Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation. 1981 Feb;63(2):307–317. doi: 10.1161/01.cir.63.2.307. [DOI] [PubMed] [Google Scholar]
  29. Whalen D. A., Jr, Hamilton D. G., Ganote C. E., Jennings R. B. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol. 1974 Mar;74(3):381–397. [PMC free article] [PubMed] [Google Scholar]
  30. Willerson J. T., Scales F., Mukherjee A., Platt M., Templeton G. H., Fink G. S., Buja L. M. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977 Apr;87(1):159–188. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES